Warning Letter Roundup: FDA Flags Labeling, Sterility, Other Violations

Drug GMP Report
A A
The FDA warned four companies for illegally branding cannabidiol products as treatments for cancer and Alzheimer’s disease.

To View This Article:

Login

Subscribe To Drug GMP Report